Company news

Intensity Therapeutics, Inc. news in 2023

Intensity Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer

December 11, 2023

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS

December 7, 2023

Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium

November 30, 2023

Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update

November 12, 2023

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023

November 1, 2023

Intensity Therapeutics Receives Orphan Drug Designation for the three key ingredients in INT230-6 for the Treatment of Soft Tissue Sarcoma

September 6, 2023

Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

September 4, 2023

Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update

August 13, 2023

Intensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update

August 6, 2023

Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds

July 9, 2023

Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds

June 28, 2023

Intensity Therapeutics Reports INT230-6 Can Cause Immune Priming in Historically Quiescent Breast Cancers

June 5, 2023

Intensity Therapeutics' INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas

June 2, 2023

Calls in 2023

Decks in 2023